FDA Approval of Pradaxa Reversal Agent is Too Late for Many Internal Bleeding Victims
In October 2015, after 5 years on the market, Federal drug regulators approved a reversal agent for the blood thinner Pradaxa, but the antidote comes too late for many former Pradaxa users who suffered severe bleeding complications while taking the controversial anticoagulant medication, which has been linked to thousands of reports of uncontrollable bleeding and other serious adverse events....
Continue reading
